Disclaimer

felbamate-oral suspension, Felbatol

GENERIC NAME: FELBAMATE - ORAL SUSPENSION (FELL-bum-ate)

BRAND NAME(S): Felbatol

Warning | Medication Uses | How To Use | Side Effects | Precautions | Drug Interactions | Overdose | Notes | Missed Dose | Storage | Medical Alert

WARNING: Because severe (sometimes fatal) blood disorders (aplastic anemia, pancytopenia) and liver problems have occurred with usage of felbamate, it should be used only in people with severe epilepsy and only after careful consideration. Aplastic anemia may occur even after the drug has been stopped. This drug is not recommended for use in those who have liver problems. Stop using this drug and immediately notify your doctor if you have symptoms of infection such as fever, chills, or persistent sore throat or if you have unusual bleeding or bruising, weakness, fatigue, dark urine, yellowing of the eyes or skin, or persistent stomach/abdominal pain. Your doctor will perform liver function tests before starting felbamate and every 1 to 2 weeks while you use this drug. Blood tests may also be performed.




Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index

copyright


STAY INFORMED

Get the Latest health and medical information delivered direct to your inbox!